An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

Overview of attention for article published in Nature Genetics, September 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

news: 1 news outlet
twitter: 15 X users
patent: 16 patents

weibo: 6 weibo users
wikipedia: 2 Wikipedia pages
f1000: 1 research highlight platform

Readers on

mendeley: 371 Mendeley

So far, Altmetric has seen 16 patents that reference this research output.

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF DISORDERS IN PATIENTS WITH…

Application EP-4775987-A2

European Patent Office

15 Jul 2026

IL-18 binding protein (IL-18BP) and antibodies for treating inflammatory diseases

Grant US-12679888-B2

United States of America

14 Jul 2026

Bispecific antibodies for use in treatment of NLRC4-GOF inflammasomapathy

Grant US-12441786-B2

United States of America

14 Oct 2025

Methods, compositions and dosing regimens for treating or preventing interferon-gamma…

Grant US-12297264-B2

United States of America

13 May 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 12 additional patents.